Paul Dodd
Directeur/Membre du Conseil chez Merck Sharp & Dohme (Holdings) Pty Ltd.
Profil
Paul Dodd is currently a Director at Merck Sharp & Dohme (Holdings) Pty Ltd.
He was formerly a Director at Viralytics Pty Ltd.
Postes actifs de Paul Dodd
| Sociétés | Poste | Début |
|---|---|---|
Merck Sharp & Dohme (Holdings) Pty Ltd.
 Merck Sharp & Dohme (Holdings) Pty Ltd. MiscellaneousMiscellaneous Merck Sharp & Dohme (Holdings) Pty Ltd. operates as an investment holding company. The company is headquartered in Macquarie Park, Australia. | Directeur/Membre du Conseil | - |
Anciens postes connus de Paul Dodd
| Sociétés | Poste | Fin |
|---|---|---|
| VIRALYTICS LTD. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
Merck Sharp & Dohme (Holdings) Pty Ltd.
Merck Sharp & Dohme (Holdings) Pty Ltd. MiscellaneousMiscellaneous Merck Sharp & Dohme (Holdings) Pty Ltd. operates as an investment holding company. The company is headquartered in Macquarie Park, Australia. | Miscellaneous |
